Multifunctional nanoparticles as a tissue adhesive and an injectable marker for image-guided procedures

Tissue adhesives have emerged as an alternative to sutures and staples for wound closure and reconnection of injured tissues after surgery or trauma. Owing to their convenience and effectiveness, these adhesives have received growing attention particularly in minimally invasive procedures. For safe and accurate applications, tissue adhesives should be detectable via clinical imaging modalities and be highly biocompatible for intracorporeal procedures. However, few adhesives meet all these requirements. Herein, we show that biocompatible tantalum oxide/silica core/shell nanoparticles (TSNs) exhibit not only high contrast effects for real-time imaging but also strong adhesive properties. Furthermore, the biocompatible TSNs cause much less cellular toxicity and less inflammation than a clinically used, imageable tissue adhesive (that is, a mixture of cyanoacrylate and Lipiodol). Because of their multifunctional imaging and adhesive property, the TSNs are successfully applied as a hemostatic adhesive for minimally invasive procedures and as an immobilized marker for image-guided procedures.

Initial Experiments Of Data Acquisition System For Tele-Handshaking

A handshake is a form of social interactions. It is important because it influences either positive or negative first impressions. This video shows a total of nine hand pressure data collected from an empirical study with a total of 42 participants. The study revealed the primary contact points of palm while handshaking. © 2013 IEEE

Recent progress in liquid embolic agents

© 2022Vascular embolization is a non-surgical procedure used to treat diseases or morbid conditions related to blood vessels, such as bleeding, arteriovenous malformation, aneurysm, and hypervascular tumors, through the intentional occlusion of blood vessels. Among various types of embolic agents that have been applied, liquid embolic agents are gaining an increasing amount of attention owing to their advantages in distal infiltration into regions where solid embolic agents cannot reach, enabling more extensive embolization. Meanwhile, recent advances in biomaterials and technologies have also contributed to the development of novel liquid embolic agents that can resolve the challenges faced while using the existing embolic materials. In this review, we briefly summarize the clinically used embolic agents and their applications, and then present selected research results that overcome the limitations of the embolic agents in use. Through this review, we suggest the required properties of liquid embolic agents that ensure efficacy, which can replace the existing agents, providing directions for the future development in this field.11Nsciescopu

Redox-Active Tyrosine-Mediated Peptide Template for Large-Scale Single-Crystalline Two-Dimensional Silver Nanosheets

Although self-assembly of various peptides has been widely applied, it is challenging to obtain single-crystalline and layer-by-layered nanostructures in a two-dimensional system. Here, we report a method for controlling the morphology and crystal growth at room temperature by a redox-active peptide template that can specifically co-assemble with metal ions. During the crystal growth, a silver ion-coordinated alpha-helical peptide (+3HN-YYACAYY-COO-) induces long-range atomic ordering at the air/water interface, which leads to multilayered single-crystalline silver nanosheets without an additional annealing process. Furthermore, this peptide template can facilitate efficient electron transfer between the independent metal nanosheets to improve electrochemical properties. We expect that this peptide template-based single-crystal growth method can be extended to synthesize other materials.N

Deep Tumor Penetration of Drug-Loaded Nanoparticles by Click Reaction-Assisted Immune Cell Targeting Strategy

Nanoparticles have been extensively used to deliver therapeutic drugs to tumor tissues through the extravasation of a leaky vessel via enhanced permeation and retention effect (EPR, passive targeting) or targeted interaction of tumor-specific ligands (active targeting). However, the therapeutic efficacy of drug-loaded nanoparticles is hampered by its heterogeneous distribution owing to limited penetration in tumor tissue. Inspired by the fact that cancer cells can recruit inflammatory immune cells to support their survival, we developed a click reaction-assisted immune cell targeting (CRAIT) strategy to deliver drug-loaded nanoparticles deep into the avascular regions of the tumor. Immune cell-targeting CD11b antibodies are modified with trans-cyclooctene to enable bioorthogonal click chemistry with mesoporous silica nanoparticles functionalized with tetrazines (MSNs-Tz). Sequential injection of modified antibodies and MSNs-Tz at intervals of 24 h results in targeted conjugation of the nanoparticles onto CD11b+ myeloid cells, which serve as active vectors into tumor interiors. We show that the CRAIT strategy allows the deep tumor penetration of drug-loaded nanoparticles, resulting in enhanced therapeutic efficacy in an orthotopic 4T1 breast tumor model. The CRAIT strategy does not require ex vivo manipulation of cells and can be applied to various types of cells and nanovehicles. © 2019 American Chemical Society11sciescopu

In Vivo Sol–Gel Reaction of Tantalum Alkoxide for Endovascular Embolization

© 2021 Wiley-VCH GmbHLiquid embolic agents are considered the most promising for various embolization procedures because they enable deep penetration. For realizing effective procedures, the delivery of liquid embolic agents should be guided under X-ray imaging systems and the solidification time should be optimized for the specific indication. The biocompatibility of embolic agents is also crucial because they remain in the vessel after embolization. In this study, new biocompatible embolic agents based on tantalum ethoxide is synthesized. Tantalum alkoxide liquid embolics (TALE) possess the radiopacity for fluoroscopy and can control the penetration depth by modifying the sol–gel kinetics. Furthermore, TALE can serve as drug carriers for synergistic treatment. Using these excellent characteristics, it is demonstrated that TALE agents can be used in various situations including the transarterial chemoembolization of hepatocellular carcinoma and embolotherapy of massive bleeding from the femoral artery.11Nsciescopu

Vertical Metal-Oxide Electrochemical Memory for High-Density Synaptic Array Based High-Performance Neuromorphic Computing

Cross-point arrays of analog synaptic devices are expected to realize neuromorphic computing hardware for neural network computations with compelling speed boost and superior energy efficiency, as opposed to the conventional hardware based on the von Neumann architecture. To achieve desired characteristics of analog synaptic devices for fully parallel vector-matrix multiplication and vector-vector outer-product updates, metal-oxide based electrochemical random-access memory (ECRAM) is proposed as a promising synaptic device due to its complementary metal-oxide-semiconductor-compatibility and outstanding synaptic characteristics over other non-volatile memory candidates. In this work, ECRAM devices with 3D vertical structure is fabricated to demonstrate a minimal 4F(2) cell size, highly scalable channel volume and low programming energy, providing optimized synaptic device performance and characteristics as well as high integrity as a cross-point array. Various weight-update profiles of the vertical ECRAM devices are obtained by adjusting programming voltage pulses, exhibiting trade-offs among dynamic range, linearity, symmetry, and update deviation. Based on simulation with advanced algorithms for analog cross-point array and neural network designs, the potential of vertical ECRAM for high-density array is evaluated. Simulation studies suggest that the neuromorphic computing performance can be improved further by balancing the weight update characteristics of vertical ECRAM.N

Large-scale synthesis and medical applications of uniform-sized metal oxide nanoparticles

Thanks to recent advances in the synthesis of high-quality inorganic nanoparticles, more and more types of nanoparticles are becoming available for medical applications. Especially, metal oxide nanoparticles have drawn much attention due to their unique physicochemical properties and relatively inexpensive production costs. To further promote the development and clinical translation of these nanoparticle-based agents, however, it is highly desirable to reduce unwanted interbatch variations of the nanoparticles because characterizing and refining each batch are costly, take a lot of effort, and, thus, are not productive. Large-scale synthesis is a straightforward and economic pathway to minimize this issue. Here, the recent achievements in the large-scale synthesis of uniform-sized metal oxide nanoparticles and their biomedical applications are summarized, with a focus on nanoparticles of transition metal oxides and lanthanide oxides, and clarifying the underlying mechanism for the synthesis of uniform-sized nanoparticles. Surface modification steps to endow hydrophobic nanoparticles with water dispersibility and biocompatibility are also briefly described. Finally, various medical applications of metal oxide nanoparticles, such as bioimaging, drug delivery, and therapy, are presented.

Large‐Scale Synthesis and Medical Applications of Uniform‐Sized Metal Oxide Nanoparticles

Thanks to recent advances in the synthesis of high-quality inorganic nanoparticles, more and more types of nanoparticles are becoming available for medical applications. Especially, metal oxide nanoparticles have drawn much attention due to their unique physicochemical properties and relatively inexpensive production costs. To further promote the development and clinical translation of these nanoparticle-based agents, however, it is highly desirable to reduce unwanted interbatch variations of the nanoparticles because characterizing and refining each batch are costly, take a lot of effort, and, thus, are not productive. Large-scale synthesis is a straightforward and economic pathway to minimize this issue. Here, the recent achievements in the large-scale synthesis of uniform-sized metal oxide nanoparticles and their biomedical applications are summarized, with a focus on nanoparticles of transition metal oxides and lanthanide oxides, and clarifying the underlying mechanism for the synthesis of uniform-sized nanoparticles. Surface modification steps to endow hydrophobic nanoparticles with water dispersibility and biocompatibility are also briefly described. Finally, various medical applications of metal oxide nanoparticles, such as bioimaging, drug delivery, and therapy, are presented.© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinhei